{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:47:18Z","timestamp":1791402438713,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.rbmo.2025.104878","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T03:10:36Z","timestamp":1740453036000},"page":"104878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Letrozole or tamoxifen co-administration during fertility preservation for patients affected by breast cancer"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-6380","authenticated-orcid":false,"given":"Dror","family":"Lifshitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Ben-Haroush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Meirow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana Vaturi","family":"Meirman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoel","family":"Shufaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Wertheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2025.104878_bib0001","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.seminoncol.2009.03.001","article-title":"Breast cancer before age 40 years","volume":"36","author":"Anders","year":"2009","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0002","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/deac145","article-title":"Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols","volume":"37","author":"Balkenende","year":"2022","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"10.1016\/j.rbmo.2025.104878_bib0003","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/09513590.2018.1534950","article-title":"Effect of letrozole added to gonadotropins in controlled ovarian stimulation protocols on the yield and maturity of retrieved oocytes","volume":"35","author":"Ben-Haroush","year":"2019","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0004","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.574669","article-title":"Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis","volume":"10","author":"Bonardi","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0006","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9378(92)91335-8","article-title":"Early menopause in long-term survivors of cancer during adolescence","volume":"166","author":"Byrne","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0007","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12958-017-0288-8","article-title":"Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?","volume":"15","author":"Haas","year":"2017","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"key":"10.1016\/j.rbmo.2025.104878_bib0008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/annonc\/mdx639","article-title":"Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients","volume":"29","author":"Lambertini","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0009","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fonc.2019.00575","article-title":"Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-m\u00fcllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy","volume":"9","author":"Lambertini","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0010","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines\u2020","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0011","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s10815-021-02273-3","article-title":"Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial","volume":"38","author":"Letourneau","year":"2021","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2025.104878_bib0012","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.rbmo.2025.104878_bib0013","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2025.104878_bib0014","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0015","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update","volume":"36","author":"Oktay","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0016","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast\/Ovarian Cancer Risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.rbmo.2025.104878_bib0017","first-page":"4338s","article-title":"Estrogen receptor: current understanding of its activation and modulation","volume":"7","author":"Osborne","year":"2001","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.rbmo.2025.104878_bib0018","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/humrep\/dex027","article-title":"The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review","volume":"32","author":"Rodgers","year":"2017","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"10.1016\/j.rbmo.2025.104878_bib0019","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.fertnstert.2015.07.1162","article-title":"BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles","volume":"104","author":"Shapira","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2025.104878_bib0020","article-title":"Long term safety of controlled ovarian stimulation for fertility preservation prior to chemotherapy treatment in breast cancer patients","volume":"0","author":"Shapira","year":"2024","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2025.104878_bib0021","doi-asserted-by":"crossref","DOI":"10.1007\/s10815-020-02030-y","article-title":"Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients","volume":"38","author":"Shulman","year":"2021","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2025.104878_bib0022","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024. CA","volume":"74","author":"Siegel","year":"2024","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.rbmo.2025.104878_bib0023","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra023246","article-title":"Aromatase inhibitors in breast cancer","volume":"348","author":"Smith","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rbmo.2025.104878_bib0024","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur. J. Endocrinol."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648325000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648325000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T06:18:21Z","timestamp":1755670701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648325000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1472648325000859"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2025.104878","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letrozole or tamoxifen co-administration during fertility preservation for patients affected by breast cancer","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2025.104878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104878"}}